Clinical Trials Browser

Gastrointestinal Diseases, Neoplasm Recurrence, Local, Prostatic Neoplasms, Radiation Injuries, Urologic Diseases

NCT06171269 2026-03-04

Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of Life

Phase NA Recruiting

60 enrolled

Genitourinary

Prostatic Neoplasms

NCT02296229 2026-02-25

Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer

Phase NA Active not recruiting

220 enrolled

Genitourinary

Prostatic Neoplasms

NCT04983095 2026-02-17

METRO

Phase NA Recruiting

118 enrolled

Genitourinary

Prostate Cancer Metastatic

NCT02454543 2026-01-12

g-RAMPP

Phase NA Active not recruiting

452 enrolled

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT02069730 2026-01-08

A Study of Drug Therapies for Salivary Gland Cancers Based on Testing of Genes

Phase NA Completed

114 enrolled

Head & Neck

Neoplasm Metastasis, Neoplasms, Recurrence, Salivary Gland Neoplasms

NCT07311915 2026-01-06

Propranolol Combined With Novel Endocrine Therapy and Androgen Deprivation Therapy (ADT) for Neoadjuvant Treatment in High-Risk Prostate Cancer Patients: A Multicenter, Single-Arm Clinical Study

Phase NA Not yet recruiting

30 enrolled

Genitourinary

Prostatic Neoplasms

NCT05746806 2025-12-31

HypoFocal SRT

Phase NA Active not recruiting

36 enrolled

Genitourinary

Prostatic Neoplasms

NCT05628363 2025-11-05

Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer

Phase NA Active not recruiting

28 enrolled

Genitourinary

Prostatic Neoplasms

NCT07172685 2025-09-15

Study on Triple Therapy Combined With HIFU for High-Tumor-Burden mHSPC

Phase NA Recruiting

116 enrolled

Genitourinary

Prostatic Neoplasms

NCT05649943 2025-09-03

APPROACH

Phase NA Recruiting

566 enrolled

Genitourinary

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

NCT07142967 2025-08-27

Trial Evaluating the Safety and Efficacy Of MR-Linac-Guided Radiotherapy as Salvage Treatment After External Beam Radiotherapy Recurrence (TUMORNATOR II)

Phase NA Recruiting

28 enrolled

Genitourinary

Intraprostatic Prostate Cancer

NCT04624828 2025-04-24

IOSCAR

Phase NA Active not recruiting

40 enrolled

Genitourinary

Oligorecurrent and Oligoprogressive Prostate Cancer Patients

Clinical Trials

HYP-OP-RT

Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of Life

Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer

METRO

g-RAMPP

A Study of Drug Therapies for Salivary Gland Cancers Based on Testing of Genes

Propranolol Combined With Novel Endocrine Therapy and Androgen Deprivation Therapy (ADT) for Neoadjuvant Treatment in High-Risk Prostate Cancer Patients: A Multicenter, Single-Arm Clinical Study

HypoFocal SRT

Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer

Study on Triple Therapy Combined With HIFU for High-Tumor-Burden mHSPC

APPROACH

Trial Evaluating the Safety and Efficacy Of MR-Linac-Guided Radiotherapy as Salvage Treatment After External Beam Radiotherapy Recurrence (TUMORNATOR II)

IOSCAR